Answers are grounded in this paper and cite their sources.
Demonstrates efficient hydroxymethylation of pyridines, suggesting novel drug modification techniques.
Pyridines are ubiquitous scaffolds in pharmaceutical chemistry and appear in approximately 90% of pyridine-derived drugs as C 2 -substituted motifs. Nevertheless, direct C–H bond molecular editing remains limited by stringent reaction conditions and low metal atom efficiency. Here, we report the first site-selective aryl-substituted 2-hydroxymethylation at the C 2 position of pyridines, enabled by relay mediation between a single-atom zinc-modified cathode and iodide ions. The protocol shows broad substrate tolerance, low metal loading, operational simplicity, negligible overpotential, and high regioselectivity. Direct molecular modification of drugs is achieved, and gram-scale synthesis of Bisacodyl is demonstrated. Mechanistic studies indicate that anodic iodide oxidation suppresses the intrinsic C 4 reactivity preference of pyridine radicals. Coupled with a relay sequence comprising adsorption, activation, electroreduction, coupling, and electrooxidation, this effect enables efficient formation of the target products. By integrating single-atom catalysis with relay paired electrolysis, this work provides a new framework for the electrocatalytic transformation of inert chemical bonds.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: